Anna Gloyn wins 2026 Transatlantic Alliance Award in Endocrinology

The European Society of Endocrinology (ESE) and the Endocrine Society are delighted to announce Dr Anna Gloyn DPhil FMedSci, as the winner of the fifth Transatlantic Alliance Award 2026

2025-12-03

(Press-News.org) The European Society of Endocrinology (ESE) and the Endocrine Society are delighted to announce Dr Anna Gloyn DPhil FMedSci, as the winner of the fifth Transatlantic Alliance Award 2026.

The Transatlantic Alliance Award, launched in 2022, recognises an international leader who has made significant advancements in endocrine research on both sides of the Atlantic - in Europe and the United States.

Dr Anna Gloyn has been honoured with this prestigious award for her exceptional work bridging the two continents. A globally recognised geneticist and endocrinologist, she is renowned for pioneering research that uncovers the genetic mechanisms underlying diabetes and advances precision medicine in diabetes care.

ESE’s President Wiebke Arlt said, “I am extremely pleased that Anna Gloyn is our 2026 Award winner. She is an inspiring example for emerging researchers who has shown exemplary leadership and her contribution to endocrine and diabetes research has been invaluable. Her career embodies true transatlantic scientific exchange, reflected in her contributions to major international research alliances, editorial boards, and her receipt of multiple accolades.”

"Dr Gloyn is an internationally recognised leader in endocrinology who has made extraordinary contributions to our understanding of the genetic basis of diabetes and has collaborated with colleagues on both sides of the Atlantic on landmark studies," said Endocrine Society President Carol Lange, Ph.D. "Her ground-breaking contributions to endocrine research across the globe and her outstanding work ethic make her an exceptional candidate for this award."

Dr Gloyn commented “For me science is all about collaboration and I continue to be fortunate to collaborate with so many incredible clinicians and scientists across Europe and the United States. I am honoured to be recognised by both societies for doing what I truly love and would like to thank all my trainees, mentors, and collaborators for enriching my scientific journey.”

She continued "I believe collaboration results in more than the sum of the parts. I learnt this as a trainee funded by an EU Horizon 2020 team science project and subsequently through multiple international consortium which bring people from both sides of the Atlantic together to move the needle in our collective efforts to improve the lives of people with diabetes.”

Dr Gloyn is Professor of Pediatrics at Stanford University, USA where she earned her DPhil at the University of Oxford, followed by post-doctoral training at the University of Exeter and the University of Pennsylvania. Her early research centered on the impact of genetic variation in KATP-channel genes, first in type 2 diabetes and later in neonatal diabetes.

In 2004, she returned to Oxford to establish an independent research program dedicated to elucidating beta-cell biology through functional characterization of genetic variants that cause monogenic diabetes. She is a member of the ClinGen expert review panel for monogenic diabetes and recently co-led the Precision Diagnostics working group for the International Precision Medicine Diabetes Initiative.

Dr Gloyn’s major focus for the past ten years has been on translating discoveries from genome-wide association studies into biological and clinical insights. Her research combines genetic discovery and functional genomics with clinical phenotyping and disease modelling in human cell models to elucidate how changes in DNA sequence alter diabetes risk. Highly collaborative, she plays roles in multiple international consortia including the Accelerated Medicines Partnership for Common Metabolic Disease (AMP-CMD) and the Human Islet Research Network (HIRN).

Dr Gloyn has received multiple national and international awards for her research including the European Association for the Study of Diabetes (EASD) Rising Star (2005) and Minkowski (2014) awards and the American Diabetes Association Outstanding Scientific Achievement Award (2022). In 2025 she was elected to the Academy of Medical Sciences in the United Kingdom.

Dr Gloyn will present her award lecture at the European Society of Endocrinology’s Annual Congress, the European Congress of Endocrinology (ECE) 2026, which is taking place from 9-12 May in Prague, Czech Republic.

Nominations for the 2027 Transatlantic Alliance Award will open early next year.

END

ELSE PRESS RELEASES FROM THIS DATE:

FAU study finds connection between poor mental health and dark web use

2025-12-03

The dark web – a hidden corner of the internet accessed through privacy-preserving tools like the Tor browser – operates beyond the reach of traditional search engines and public platforms. Unlike the surface web, its architecture is deliberately designed to shield identities and activities from view, prioritizing anonymity over transparency. Although the dark web has existed for more than 20 years, research assessing mental health differences between its users and those who stay on the surface web remains limited. Its pseudo-anonymous ...

A new study finds high-narcissism CEOs pursue more acquisitions in response to strong firm performance

2025-12-03

Managers’ narcissistic tendencies may fundamentally affect whether a company makes risky or safe moves as a response to the firm’s above-aspiration performance, according to a new study published in Strategic Management Journal. In a study that helps to clarify prior conflicting research, the researchers find evidence that high-narcissism CEOs respond to above-aspiration performance with more acquisitions, while low-narcissism CEOs avoid acquisitions. The study authors — Korcan Kavusan of Erasmus University, Daniel Z. Mack of Singapore Management University, Matthew P. Mount of ...

During times of market volatility, investors should track insider trades

2025-12-03

PULLMAN, Wash. — In times of economic upheaval, investors can get a clearer picture of the stock market’s future performance if they tune into how corporate insiders are trading stocks in their own companies. That’s a key finding from a new study of investor behavior during the Covid-19 pandemic from Washington State University researchers. The study, which was published in Pacific-Basin Finance Journal, examined the trading choices of insiders during the unprecedented market shocks of the Covid-19 pandemic — finding they often zigged when the market zagged. When most investors were selling stocks ...

Fish freshness easily monitored with a new sensor

2025-12-03

To see if a fish is fresh, people recommend looking at its eyes and gills or giving it a sniff. But a more accurate check for food quality and safety is to look for compounds that form when decomposition starts. Now, researchers reporting in ACS Sensors have developed a simple, effective electronic device that quickly measures one of these compounds. The prototype sensor can determine how fresh a fish is in less than two minutes. For fish, signs of spoilage (cloudy eyes, bruised gills, foul or fishy odors) might take hours or even days to appear. In contrast, compounds such as hypoxanthine (HX) start forming ...

Antibiotics could trigger immune response through gut microbiome metabolites

2025-12-03

The microbes inside our bodies not only help break down food but also impact our health. Yet their precise influence is not always understood, especially in the presence of prescription drugs. Now, researchers in ACS Central Science report how one of the most abundant gut bacteria responds to tetracyclines, a class of commonly prescribed antibiotics. Newly characterized signals released by the bacterium could aid the host’s immune response, inhibit pathogens and restructure the gut microbiome. “We previously showed that exogenous molecules ...

New Family Heart Foundation study finds only 13% of adults with cardiovascular disease achieve comprehensive LDL-C management

2025-12-03

FERNANDINA BEACH, Fla., December 3, 2025 – The Family Heart Foundation, a leading research and advocacy organization, published new research in the American Journal of Preventive Cardiology revealing significant gaps in cholesterol management during 2022-23 among U.S. adults with atherosclerotic cardiovascular disease (ASCVD). Findings show that only 13% of adults with ASCVD were meeting three key components of optimal low-density lipoprotein-cholesterol (LDL-C) management, including receiving guideline-recommended therapy, consistently taking ...

UT San Antonio physicists' groundbreaking discoveries open new paths to combating diseases

2025-12-03

Researchers at UT San Antonio have uncovered new details about electrical signals happening within nerve cells, deepening scientists’ understanding of the brain. The UT San Antonio research team and international collaborators investigating the electrical activity inside neurons are led by Marcelo Marucho, professor of physics and astronomy and member of the department’s Biophysics Group, and Md Mohsin, a doctoral student pursuing his PhD in Physics. “Understanding how electrical processes work could be crucial for linking the behavior of the cell’s ...

Operando X-ray tomography reveals silicon–electrolyte interface dynamics in all-solid-state batteries

2025-12-03

All-solid-state batteries (ASSBs) using silicon (Si) anodes are among the most promising candidates for high-energy and long-lasting power sources, particularly for electric vehicles. Si can store more lithium than conventional graphite, but its volume expands by roughly 410% during charging. This swelling generates mechanical stress that cracks particles and weakens their contact with the solid electrolyte, disrupting the flow of ions and reducing efficiency. To address this, a research group led by Professor Yuki Orikasa from the College of Life Sciences, Ritsumeikan University, ...

Building better, building beautiful

2025-12-03

A researcher from the University of Tokyo and a U.S.-based structural engineer developed a new computational form-finding method that could change how architects and engineers design lightweight and free-form structures covering large spaces. The technique specifically helps create gridshells, thin, curved surfaces whose members form a networked grid. The method makes use of NURBS surfaces, a widely used surface representation format in computer-aided design (CAD). It also drastically reduces computation cost — a task that previously took 90 hours on a high-end GPU completes in about 90 minutes on a standard CPU. Architects pay particular attention to surfaces capable of supporting ...

Okayama University chemists pioneer light-driven macrolactone synthesis

2025-12-03

Macrolactones—large ring lactones—are core components of many natural products and pharmaceutical agents. Traditional synthetic routes rely on seco acids activated with condensing reagents, often requiring harsh conditions or multi-step procedures. An alternative approach using hydroxyaldehydes has remained limited, and radical-based macrolactonization of these substrates had never been reported. Now, a research team led by Dr. Kenta Tanaka, Assistant Professor at the Research Institute for Interdisciplinary ...

LAST 30 PRESS RELEASES: